Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration

被引:89
作者
Gärtner, U [1 ]
Holzer, M [1 ]
Arendt, T [1 ]
机构
[1] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Neuroanat, D-04109 Leipzig, Germany
关键词
cell cycle; mitogen-activated protein kinase; neurodegeneration; neuronal plasticity; sprouting;
D O I
10.1016/S0306-4522(99)00059-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease is a chronic degenerative disorder characterized by the intracellular accumulation of "paired helical filaments" consisting of highly phosphorylated tau and by extracellular deposits of aggregated A beta-peptide. Furthermore, neurodegeneration in Alzheimer's disease is associated with the appearance of neuritic growth profiles that are aberrant with respect to their localization, morphological appearance, and composition of cytoskeletal elements.(2) During early stages of Alzheimer's disease, a variety of growth factors and mitogenic compounds(10,12,15,16,18,32) are elevated. Most of these factors mediate their cellular effects through activation of the p21(ras)-dependent mitogen-activated protein kinase cascade, a pathway that is also involved in the regulation of expression and post-translational modification of the amyloid precursor protein and tau protein.(7,11,13,14,19,20,22,31) We previously reported on the elevated expression of p21(ras) associated with paired helical filament formation and A beta-deposits.(17) However, the question arises as to whether induction of p21(ras) and the downstream mitogen-activated protein kinase cascade is an early event with rather primary importance in the pathogenetic chain or simply occurs as a cellular response to neurodegeneration.(29) The present study shows that expression of p21(ras) is clearly elevated in very early stages of the disease, preceding both neurofibrillary pathology and formation of A beta. (C) 1999 IBRO, Published by Elsevier Science Ltd.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 35 条
[1]  
Arendt T, 1998, J NEURAL TRANSM-SUPP, P147
[2]  
Arendt T, 1996, NEUROREPORT, V7, P3047
[3]   INCREASED EXPRESSION AND SUBCELLULAR TRANSLOCATION OF THE MITOGEN-ACTIVATED PROTEIN-KINASE KINASE AND MITOGEN-ACTIVATED PROTEIN-KINASE IN ALZHEIMERS-DISEASE [J].
ARENDT, T ;
HOLZER, M ;
GROSSMANN, A ;
ZEDLICK, D ;
BRUCKNER, MK .
NEUROSCIENCE, 1995, 68 (01) :5-18
[4]   Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease [J].
Arendt, T ;
Holzer, M ;
Gärtner, U .
JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (8-9) :949-960
[5]   DENDRITIC REORGANIZATION IN THE BASAL FOREBRAIN UNDER DEGENERATIVE CONDITIONS AND ITS DEFECTS IN ALZHEIMERS-DISEASE .2. AGING, KORSAKOFFS DISEASE, PARKINSONS-DISEASE, AND ALZHEIMERS-DISEASE [J].
ARENDT, T ;
BRUCKNER, MK ;
BIGL, V ;
MARCOVA, L .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 351 (02) :189-222
[6]  
Arendt T, 1993, BIOL CHEM HOPPESEYLE, V374, P911
[7]   HYPERPHOSPHORYLATION OF HUMAN-TAU BY BRAIN KINASE PK40(ERK) BEYOND PHOSPHORYLATION BY CAMP-DEPENDENT PKA - RELATION TO ALZHEIMERS-DISEASE [J].
BLANCHARD, BJ ;
RAGHUNANDAN, RD ;
RODER, HM ;
INGRAM, VM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :187-194
[8]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[9]  
Busser J, 1998, J NEUROSCI, V18, P2801
[10]   Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampus [J].
Connor, B ;
Beilharz, EJ ;
Williams, C ;
Synek, B ;
Gluckman, PD ;
Faull, RJM ;
Dragunow, M .
MOLECULAR BRAIN RESEARCH, 1997, 49 (1-2) :283-290